SANA

Sana Biotechnology's stock has fluctuated due to clinical updates and conference presentations. As of May 7, 2026, the share price was $3.50, a 93.37% increase over the year, but a 16.47% year-to-date decline. Key events include Q4 2025 earnings report with an EPS of -$0.16, presentations at conferences, a strategic collaboration with Mayo Clinic for Type 1 Diabetes, and an oral presentation on preclinical data from in vivo CAR T SG293. Investor focus remains on pipeline progress despite ongoing losses.